Add Company
Join Now

Provectus Biopharmaceuticals Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Provectus Biopharmaceuticals's estimated annual revenue is currently $1.9M per year.(i)
  • Provectus Biopharmaceuticals's estimated revenue per employee is $155,000

Employee Data

  • Provectus Biopharmaceuticals has 12 Employees.(i)
  • Provectus Biopharmaceuticals grew their employee count by 0% last year.

Provectus Biopharmaceuticals's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M110%N/AN/A
#2
$5M3214%N/AN/A
#3
$3.6M235%N/AN/A
#4
$1.1M7-22%N/AN/A
#5
$1.7M110%N/AN/A
#6
$0.8M50%N/AN/A
#7
$6M3950%N/AN/A
#8
$0.9M60%N/AN/A
#9
$4.8M31-6%N/AN/A
#10
$1.9M120%N/AN/A
Add Company

What Is Provectus Biopharmaceuticals?

Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. Provectus’ investigational oncology drug, PV-10, is an ablative immunotherapy under investigation in solid tumor cancers.

keywords:N/A

N/A

Total Funding

12

Number of Employees

$1.9M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M12-8%N/A
#2
$2.1M12-65%N/A
#3
$1M129%N/A
#4
$1M120%N/A
#5
$1.2M14-12%N/A